CYDUCT Diagnostics, Inc. (OTCMKTS:CYDX)
WESTPORT, CT, UNITED STATES, August 7, 2026 /EINPresswire.com/ — CYDUCT Diagnostics, Inc. (OTCPK: CYDX) (“CYDUCT”, or the “Company”), a women’s health company developing technologies to support earlier detection and more precise breast health management, today announced the development of a new corporate branding strategy as the company prepares to advance its commercial platform and pursue broader market expansion in 2027.
“As CYDUCT moves into its next stage of growth, our brand must communicate both the scientific foundation of our technology and its potential to transform the way breast health is assessed and managed,” said CEO Dom Gatto. “This initiative will create a stronger, more cohesive market presence while ensuring that our purpose delivering earlier insight and enabling more informed action remains at the center of everything we do.”
The new branding strategy is intended to support CYDUCT’s transition from technology development toward commercial readiness by establishing a scalable platform for future product introductions, clinical collaborations and market expansion. The company expects to begin introducing elements of the refreshed brand across its corporate communications, digital channels and stakeholder materials in advance of its planned 2027 growth initiatives as early as this month.
“CYDUCT is building more than a new brand identity,” added Dom Gatto. “We are creating a clear and compelling expression of where the company is going, the clinical need we are addressing and the value our technology may bring to the future of breast health management.”
Additional information on its line of products will be available on the Company’s website at: www.CYductDX.com.
FORWARD-LOOKING STATEMENTS; ADDITIONAL INFORMATION
This press release includes certain information that may constitute forward-looking statements. Forward-looking statements are typically identified by terminology such as “could,” “may,” “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “proposed,” “planned,” “potential” and similar expressions, or are those, which, by their nature, refer to future events. All statements, other than statements of historical fact, included herein, including statements about CYDUCT’s while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. Although CYDUCT believes that such statements are reasonable, it can give no assurance that such forward-looking information will prove to be accurate. CYDUCT cautions investors that any forward-looking statements by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward-looking statements as a result of various factors. Accordingly, due to the risks, uncertainties and assumptions inherent in forward-looking information, readers and prospective investors in the Company’s securities should not place undue reliance on forward-looking information. All forward-looking information contained in this press release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof and is subject to change. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company’s Annual Report filing and other filings with the OTC Markets Group (available at www.otcmarkets.com). The Company assumes no obligation to revise or update forward-looking information to reflect new circumstances, whether as a result of new information, future events or otherwise, except as required by law.
CONTACT:
CYDUCT Diagnostics, Inc.
Investor Relations +1-888-545-9112
SOURCE: CYDUCT Diagnostics, Inc.
Elise Grubb
CYDUCT Diagnostics, Inc.
email us here
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
